Glenmark Pharmaceuticals
GLENMARK.NS
₹2,181
Share price
14.55%
Change (1 day)
57.51%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt
Total debt on the balance sheet as of March 2025 : ₹24.81 Billion
According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is ₹24.81 Billion. A company’s total debt is the sum of all current and non-current debts.
Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | ₹12.30 B | -73.29% |
| 2023-03-31 | ₹46.07 B | 16.3% |
| 2022-03-31 | ₹39.62 B | -20.53% |
| 2021-03-31 | ₹49.85 B | -3.86% |
| 2020-03-31 | ₹51.85 B | 16.57% |
| 2019-03-31 | ₹44.48 B | -4.11% |
| 2018-03-31 | ₹46.39 B | -1.78% |
| 2017-03-31 | ₹47.23 B | 18.44% |
| 2016-03-31 | ₹39.88 B | 4.95% |
| 2015-03-31 | ₹37.99 B | 16.31% |
| 2014-03-31 | ₹32.66 B | 18.16% |
| 2013-03-31 | ₹27.64 B | 23.18% |
| 2012-03-31 | ₹22.44 B | 6.45% |
| 2011-03-31 | ₹21.08 B | 12.79% |
| 2010-03-31 | ₹18.69 B | -10.74% |
| 2009-03-31 | ₹20.94 B | 111.35% |
| 2008-03-31 | ₹9.90 B | 5.79% |
| 2007-03-31 | ₹9.36 B | 27.37% |
| 2006-03-31 | ₹7.35 B | 68.1% |
| 2005-03-31 | ₹4.37 B | 280.83% |
| 2004-03-31 | ₹1.14 B |